BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS • Currently up 0.08 (+0.14%) in today's trading session

1 member of Congress has disclosed 1 trade in BioMarin Pharmaceutical Inc. (BMRN) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 18 October 2021. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

BioMarin Pharmaceutical Inc. is currently trading at $53.98, positioned at 21% of its 52-week range ($50.76 – $66.28).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$53.98
24h Change
+0.08 (+0.14%)
52 Week Range
$50.76—$66.28
View on NASDAQ

BioMarin Pharmaceutical Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BMRN

Select to highlight on chart
1 transactions
Compliance: 100%
Josh Gottheimer18 Oct 202115 Nov 2021SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$10.38B

Volume

193.28K

Beta

0.29

P/E Ratio

29.99

Fundamentals

EPS

$1.80

Div. Yield

—

Open

$53.91

Day Range

$53.56 — $54.14

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Alexander Hardy
IPO Date
1999-07-26
Website
www.biomarin.com

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopoly...

Earnings

Next Report

Q1 2026

4 May

EPS Est.

$1.00

Rev. Est.

$753.5M

Days Until

3

Recent Quarters

Q4 202523 Feb
EPS$-0.24
Miss 241.7%
Q3 202527 Oct
EPS$0.12
Beat 180.0%
Q2 20254 Aug
EPS$1.44
Beat 67.3%
Q1 20251 May
EPS$1.13
Beat 20.2%
Q4 202419 Feb
EPS$0.92
Beat 70.4%
Q3 202429 Oct
EPS$0.91
Beat 16.7%
Q2 20245 Aug
EPS$0.96
Beat 168.3%
Q1 202424 Apr
EPS$0.71
Beat 127.7%
Q4 202322 Feb
EPS$0.49
Beat 11.4%
Q3 20231 Nov
EPS$0.46
Beat 0.0%
Q2 202331 Jul
EPS$0.54
Beat 14.9%
Q1 202326 Apr
EPS$0.60
Beat 39.5%
Q4 202227 Feb
EPS$0.36
Beat 614.3%
Q3 202226 Oct
EPS$0.45
Beat 21.6%
Q2 20223 Aug
EPS$0.59
Beat 37.2%
Q1 202227 Apr
EPS$0.55
Beat 44.7%
Q4 202123 Feb
EPS$0.03
Beat 0.4%
Q3 202127 Oct
EPS$0.18
Beat 63.6%
Q2 202128 Jul
EPS$0.53
Beat 76.7%
Q1 202129 Apr
EPS$0.56
Beat 75.0%
Q4 202025 Feb
EPS$0.21
Beat 23.5%
Q3 20205 Nov
EPS$0.54
Beat 116.0%
Q2 20204 Aug
EPS$0.32
Beat 100.0%
Q1 202029 Apr
EPS$0.63
Beat 90.9%
Q4 201926 Feb
EPS$0.25
Beat 19.1%
Q3 201923 Oct
EPS$0.43
Beat 26.5%
Q2 20191 Aug
EPS$0.09
Miss 47.1%
Q1 201925 Apr
EPS$0.14
Beat 55.6%
Q4 201821 Feb
EPS$-0.07
Miss 170.0%
Q3 201825 Oct
EPS$0.14
Beat 7.7%
Q2 20182 Aug
EPS$0.12
Miss 29.4%
Q1 201825 Apr
EPS$0.11
Miss 15.4%
Q4 201722 Feb
EPS$-0.30
Miss 25.0%
Q3 201726 Oct
EPS$-0.07
Beat 41.7%
Q2 20172 Aug
EPS$0.15
Beat 168.2%
Q1 20174 May
EPS$-0.09
Beat 70.0%
Q4 201623 Feb
EPS$-0.53
Miss 35.9%
Q3 201627 Oct
EPS$-0.26
Beat 33.3%
Q2 20164 Aug
EPS$-2.61
Miss 411.8%
Q1 201628 Apr
EPS$-0.53
Beat 37.6%
Q4 201525 Feb
EPS$0.39
Miss 60.6%
Q3 201529 Oct
EPS$-0.60
Beat 9.1%
Q2 20153 Aug
EPS$-0.51
Beat 3.8%
Q1 201530 Apr
EPS$-0.43
Beat 18.9%
Q4 201425 Feb
EPS$-0.47
Beat 20.3%
Q3 201423 Oct
EPS$-0.16
Beat 27.3%
Q2 201430 Jul
EPS$-0.23
Beat 45.2%
Q1 20141 May
EPS$-0.27
Beat 44.9%
Q4 201326 Feb
EPS$-0.11
Beat 67.7%
Q3 201324 Oct
EPS$-0.38
Miss 26.7%
Q2 201325 Jul
EPS$-0.16
Beat 42.9%
Q1 201325 Apr
EPS$-0.31
Miss 10.7%
Q4 201221 Feb
EPS$-0.43
Miss 65.4%
Q3 201225 Oct
EPS$-0.04
Beat 81.0%
Q2 20121 Aug
EPS$-0.27
Miss 28.6%
Q1 201226 Apr
EPS$-0.21
Miss 50.0%
Q4 201116 Feb
EPS$-0.23
Miss 109.1%
Q3 201127 Oct
EPS$-0.14
Miss 27.3%
Q2 201128 Jul
EPS$-0.05
Beat 54.5%
Q1 201128 Apr
EPS$-0.04
Beat 60.0%
Q4 201017 Feb
EPS$-0.11
Miss 141.5%
Q3 201028 Oct
EPS$1.68
Beat 15228.5%
Q2 20102 Aug
EPS$-0.00
Miss 138.8%
Q1 201029 Apr
EPS$0.01
Q4 200923 Feb
EPS$0.05
Beat 325.2%
Q3 200928 Oct
EPS$0.06
Beat 985.0%
Q2 200930 Jul
EPS$0.01
Beat 185.5%
Q1 200930 Apr
EPS$-0.13
Miss 8.3%
Q4 200818 Feb
EPS$0.21
Miss 19.2%
Q3 200828 Oct
EPS$0.01
Miss 69.6%
Q2 20085 Aug
EPS$0.04
Beat 30.3%
Q1 200829 Apr
EPS$0.02
Beat 140.0%
Q4 200726 Feb
EPS$0.03
Miss 23.5%
Q3 20071 Nov
EPS$-0.05
Beat 50.0%
Q2 20077 Aug
EPS$-0.04
Beat 33.3%
Q1 200730 Apr
EPS$-0.10
Beat 9.1%
Q4 200620 Feb
EPS$-0.11
Beat 15.4%
Q3 20061 Nov
EPS$-0.08
Beat 38.5%
Q2 20062 Aug
EPS$-0.02
Beat 81.8%
Q1 20063 May
EPS$-0.13
Beat 38.1%
Q4 200523 Feb
EPS$-0.20
Beat 9.1%
Q3 20051 Nov
EPS$-0.21
Beat 25.0%
Q2 20051 Aug
EPS$-0.33
Beat 5.7%
Q1 20055 May
EPS$-0.35
Beat 0.0%
Q4 200423 Feb
EPS$-0.23
Beat 30.3%
Q3 20043 Nov
EPS$-0.40
Miss 11.1%
Q2 20049 Aug
EPS$-0.28
Beat 3.5%
Q1 20044 May
EPS$-0.31
Beat 0.0%
Q4 20033 Feb
EPS$-0.40
Miss 5.3%
Q3 20034 Nov
EPS$-0.33
Beat 15.4%
Q2 20035 Aug
EPS$-0.14
Beat 12.5%
Q1 20035 May
EPS$-0.35
Miss 25.0%
Q4 20029 Feb
EPS$-0.36
Miss 2.9%
Q3 200231 Oct
EPS$-0.32
Miss 3.2%
Q2 20021 Aug
EPS$-0.27
Beat 6.9%
Q1 20027 May
EPS$-0.51
Miss 54.5%
Q4 200125 Feb
EPS$-0.34
Miss 13.3%
Q3 200126 Oct
EPS$-0.26
Beat 13.3%
Q2 200127 Jul
EPS$-0.30
Miss 15.4%
Q1 200127 Apr
EPS$-0.26
Beat 0.0%
Q4 200022 Feb
EPS$-0.28
Beat 15.2%
Q3 200030 Oct
EPS$-0.23
Beat 20.7%
Q2 200028 Jul
EPS$-0.19
Beat 29.6%
Q1 200028 Apr
EPS$-0.34
Miss 30.8%
Q4 199918 Feb
EPS$-0.26
Beat 0.0%
Q3 199915 Nov
EPS$-0.24
Q3 19991 Nov
EPS$-0.24
Miss 9.1%
Q4 199831 Mar
EPS$-0.75

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BMRN

Which members of Congress have traded BMRN?
1 member of Congress has disclosed 1 trade in BioMarin Pharmaceutical Inc. (BMRN) under the STOCK Act: Josh Gottheimer.
When was BMRN most recently disclosed by Congress?
The most recent BMRN disclosure was a sale by Josh Gottheimer on 18 October 2021.
What is the total disclosed congressional trading volume for BMRN?
Members of Congress have disclosed approximately $8K in BMRN sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BMRN?
This BMRN page updates as soon as new STOCK Act disclosures are filed for BioMarin Pharmaceutical Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.